Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 3,917 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hypertension Clear all

Conditions: Hypertension
Interventions: SMI, HEI, UC; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 533 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: SMBP with clinical pharmacist support; Behavioral
Lead sponsor: Korey Kennelty; Other
Eligibility: 65 Years and older
Enrollment: 930 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: Iowa City, Iowa

Conditions: Renal Artery Obstruction, Hypertension, Renal
Interventions: Herculink Elite Renal Stent System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Santa Clara, California

Conditions: Hypertension
Interventions: Artificial Intelligence (AI) Activity, 10,000 steps; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Subarachnoid Hemorrhage, Hypertension
Interventions: Clevidipine butyrate injectable emulsion; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Hypertension
Interventions: DASH diet, Delayed Intervention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypertension
Interventions: Nebivolol, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 36
States / cities: Foley, Alabama • Montgomery, Alabama • Chino, California + 30 more

Conditions: Hypertension, Cardiovascular Disease, Metabolic Disorders
Interventions: Not listed
Lead sponsor: San Diego State University; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 304 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Preeclampsia
Interventions: Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections; Other
Lead sponsor: Indiana University; Other
Eligibility: 26 Weeks and older
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension, Lung Diseases, Carnitine Nutritional Deficiency
Interventions: L-carnitine; Dietary Supplement
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Chronic Venous Hypertension Due to Deep Vein Thrombosis, Venous Reflux
Interventions: exercise in water, aquatic activity plus conventional management; Other
Lead sponsor: Arizona Cardiovascular Consultants; Other
Eligibility: 18 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Hypertension
Interventions: Technology-enabled Team Care, Enhanced Usual Care; Other
Lead sponsor: East Carolina University; Other
Eligibility: 19 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Greenville, North Carolina • Wilmington, North Carolina

Conditions: Open-Angle Glaucoma, Ocular Hypertension
Interventions: Bimatoprost (SR); Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 515 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 38
States / cities: Sun City, Arizona • Huntington Beach, California • Irvine, California + 32 more

Conditions: Intracerebral Hemorrhage, Stroke, Hypertension
Interventions: Blood pressure management policies; Other
Lead sponsor: The George Institute; Other
Eligibility: 18 Years and older
Enrollment: 2,839 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypertension
Interventions: valsartan plus hydrochlorothiazide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 1,171 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Atherosclerosis, Congestive Heart Failure, Left Ventricular Hypertrophy, Diabetes Mellitus, Hypertension, Obesity, Metabolic Syndrome X, Myocardial Infarction
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 35 Years to 70 Years
Enrollment: 3,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Hypertension, Cardiovascular Disease Acute, Hyperlipidemia, Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD, Peripheral Artery Disease, Metabolic Syndrome, Prediabetes
Interventions: Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent; Device · Drug
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: Blood draw; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Hypertension
Interventions: CROWN Intervention, Enhanced Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pulmonary Hypertension
Interventions: Low-level tragus stimulation, Sham stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Heart Failure
Interventions: Dietary Approaches to Stop Hypertension Diet; Other
Lead sponsor: University of Georgia; Other
Eligibility: 65 Years to 110 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Obesity, Diabetes, Hypertension, Hyperlipidemia
Interventions: Exercise, Reduced Calorie Diet, Weight Maintenance Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 65 Years and older
Enrollment: 167 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Intra-Abdominal Hypertension
Interventions: Accuryn Foley catheter device; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Glaucoma
Interventions: AR-12286 0.5% ophthalmic solution, AR-12286 0.25% Ophthalmic solution, Latanoprost ophthalmic solution; Drug
Lead sponsor: Aerie Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 18
States / cities: Inglewood, California • Petaluma, California • Poway, California + 15 more

Search by objective public record fields.

A Behavioral Intervention To Improve Hypertension Control In Veterans

SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis

AI Activity Study in Patients With Elevated Blood Pressure

Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

Translating Dietary Trials Into the Community

Nebivolol in Patients With Systolic Stage 2 Hypertension

Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women

Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

The ATLANTIS Trial

Heart to Heart: BP Control Partners

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort

Truway Diagnostic Tools in Primary Care

Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)

Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women

Neuromodulation in Patients With Pulmonary Arterial Hypertension

Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)

Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults

Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure